PMDA drug package insert

クロルジアゼポキシド錠5mg「ツルハラ」

PMDA Prescription drug · 鶴原製薬株式会社 · package insert Sep 12, 2023

Key facts

Brand names クロルジアゼポキシド錠5mg「ツルハラ」, クロルジアゼポキシド錠10mg「ツルハラ」, クロルジアゼポキシド散1%「ツルハラ」
Nonproprietary names クロルジアゼポキシド
Companies 製造販売元/鶴原製薬株式会社
Product type Prescription drug
Therapeutic category 抗不安剤
Therapeutic category codes 871124
YJ codes 1124028F1056, 1124028F2087, 1124028B1062
Approval numbers 22500AMX00768000, 22500AMX00769000, 22500AMX00739000
Package insert edition 第1版
Package insert date Sep 12, 2023
PMDA document key 460028_1124028B1062_1
PMDA company code 460028

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • 1–9 Safety communications
  • No PMDA review report published
  • No Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)